Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

US Patent 9321737 · Granted Apr 26, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinoline-based compounds and methods of inhibiting CDK8/192025
Bicyclic pyridine compositions and methods of using the same for cancer therapy2023
Quinoline-based compounds and methods of inhibiting CDK8/192021
CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreven2021
CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreven2021
Cell-based methods for measuring activity of a protein inhibitor2020
Cell-based methods for measuring activity of a protein inhibitor2020
8-carboxamido-2,6-methano-3-benzazocines2018
Method for treating prostate cancer2017
Carboxamide bioisosteres of opiates2016
CDKI pathway inhibitors and uses thereof2016
CDKI pathway inhibitors and uses thereof2016